Literature DB >> 29434902

Chloroquine exerts antitumor effects on NB4 acute promyelocytic leukemia cells and functions synergistically with arsenic trioxide.

Shousheng Liu1, Xiuyu Cai1, Liangping Xia1, Chang Jiang1, Ping Chen1, Xiaopai Wang2, Bei Zhang1, Hong Yun Zhao3.   

Abstract

Chloroquine (CQ) has been confirmed to exhibit antitumor effects on different types of cancer cell, but whether it exerts the same effect on acute promyelocytic leukemia (APL) cells remains to be confirmed. In the present study, the effects of various concentrations of CQ on the growth, apoptosis and cell cycle distribution of NB4 cells, as well as the potential mechanisms underlying these effects, were examined. The combined effect of CQ and arsenic trioxide (ATO) on the growth of NB4 cells was also determined. The results of the present study demonstrated that CQ treatment inhibited cell proliferation, and induced mitochondrial pathway apoptosis and S phase arrest in a dose-dependent manner by regulating apoptosis- and cell cycle-related proteins. CQ and ATO had a synergistic effect on the growth inhibition of NB4 cells, which may have been induced through the inhibition of autophagy. In conclusion, the results of the present study indicated that CQ exhibits a cytotoxic effect on NB4 cells and has a synergistic effect when combined with ATO, which thereby improves the curative effect of ATO on APL.

Entities:  

Keywords:  apoptosis; arsenic trioxide; autophagy; cell cycle; chloroquine

Year:  2017        PMID: 29434902      PMCID: PMC5774501          DOI: 10.3892/ol.2017.7488

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  41 in total

1.  Solid tumors subsequent to arsenic trioxide treatment for acute promyelocytic leukemia.

Authors:  Wing-Yan Au; Cyrus R Kumana; Ching-Wan Lam; Vincent C C Cheng; Tony W Shek; Eric Y T Chan; Rico Liu; Yok-Lam Kwong
Journal:  Leuk Res       Date:  2006-05-24       Impact factor: 3.156

2.  Methods for assessing autophagy and autophagic cell death.

Authors:  Ezgi Tasdemir; Lorenzo Galluzzi; M Chiara Maiuri; Alfredo Criollo; Ilio Vitale; Emilie Hangen; Nazanine Modjtahedi; Guido Kroemer
Journal:  Methods Mol Biol       Date:  2008

3.  Regulation of PIK3C3/VPS34 complexes by MTOR in nutrient stress-induced autophagy.

Authors:  Hai-Xin Yuan; Ryan C Russell; Kun-Liang Guan
Journal:  Autophagy       Date:  2013-12       Impact factor: 16.016

4.  HIF1-alpha functions as a tumor promoter in cancer associated fibroblasts, and as a tumor suppressor in breast cancer cells: Autophagy drives compartment-specific oncogenesis.

Authors:  Barbara Chiavarina; Diana Whitaker-Menezes; Gemma Migneco; Ubaldo E Martinez-Outschoorn; Stephanos Pavlides; Anthony Howell; Herbert B Tanowitz; Mathew C Casimiro; Chenguang Wang; Richard G Pestell; Philip Grieshaber; Jaime Caro; Federica Sotgia; Michael P Lisanti
Journal:  Cell Cycle       Date:  2010-09-04       Impact factor: 4.534

5.  Mechanisms of resistance to apoptosis in the human acute promyelocytic leukemia cell line NB4.

Authors:  I Gañán-Gómez; M C Estañ-Omaña; P Sancho; P Aller; M C Boyano-Adánez
Journal:  Ann Hematol       Date:  2014-10-18       Impact factor: 3.673

6.  Induction of cell cycle arrest and apoptosis in JAR trophoblast by antimalarial drugs.

Authors:  Athip Nilkaeo; Suthinee Bhuvanath; Sakonwun Praputbut; Seuptrakool Wisessombat
Journal:  Biomed Res       Date:  2006-06       Impact factor: 1.203

Review 7.  Chloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapies.

Authors:  V Raja Solomon; Hoyun Lee
Journal:  Eur J Pharmacol       Date:  2009-10-15       Impact factor: 4.432

Review 8.  The roles of therapy-induced autophagy and necrosis in cancer treatment.

Authors:  Ravi K Amaravadi; Craig B Thompson
Journal:  Clin Cancer Res       Date:  2007-12-15       Impact factor: 12.531

9.  Inhibition of mTOR pathway sensitizes acute myeloid leukemia cells to aurora inhibitors by suppression of glycolytic metabolism.

Authors:  Ling-Ling Liu; Zi-Jie Long; Le-Xun Wang; Fei-Meng Zheng; Zhi-Gang Fang; Min Yan; Dong-Fan Xu; Jia-Jie Chen; Shao-Wu Wang; Dong-Jun Lin; Quentin Liu
Journal:  Mol Cancer Res       Date:  2013-09-05       Impact factor: 5.852

10.  Arsenic trioxide and resveratrol show synergistic anti-leukemia activity and neutralized cardiotoxicity.

Authors:  Yuhua Fan; Meng Chen; Jia Meng; Lei Yu; Yingfeng Tu; Lin Wan; Kun Fang; Wenliang Zhu
Journal:  PLoS One       Date:  2014-08-21       Impact factor: 3.240

View more
  3 in total

1.  Knockdown of neuron-specific enolase suppresses the proliferation and migration of NCI-H209 cells.

Authors:  Xia Liu; Shousheng Liu; Juan Fu; Jinsheng Huang; Chengyin Weng; Xisheng Fang; Mingmei Guan; Yong Wu; Lin Yang; Guolong Liu
Journal:  Oncol Lett       Date:  2019-09-04       Impact factor: 2.967

Review 2.  Chloroquine against malaria, cancers and viral diseases.

Authors:  Wenmin Zhou; Hui Wang; Yuqi Yang; Zhe-Sheng Chen; Chang Zou; Jianye Zhang
Journal:  Drug Discov Today       Date:  2020-09-16       Impact factor: 7.851

3.  Melatonin enhances arsenic trioxide-induced cytotoxicity by modulating autophagy in an acute promyelocytic leukemia cell line.

Authors:  Xia Wei; Xin Pu; Sainan Yang; Xiaoqin Meng; Xue Chen; Zhihua Zhang; Xaomin Sheng; Dan Xiang; Yong Zhang
Journal:  Transl Cancer Res       Date:  2019-09       Impact factor: 1.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.